NCT05469438Completed
IMAS Optimization and Applicability in Acute and Subacute Stroke.
Source: ClinicalTrials.gov · Last updated 2 Dec 2025
Brief summary (registry, in English)
The investigator will investigate our Integrated sensor-based Motion Analysis Suite (IMAS) to objectively and quantitatively measure acute stroke patient motor status.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 16 Mar 2022
- Start date
- 29 Oct 2021
- Primary completion date
- 31 Aug 2023
- Lead sponsor
- Case Western Reserve University
- Diseases
- Stroke
- NCT number
- NCT05469438
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 29 Oct 2021 to the primary completion date, 31 Aug 2023
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of dementia per relative/ medical records.
- Presence of receptive aphasia at baseline or after the current acute stroke.
- Need for rapid clinical response due to conditions such as psychosis, or suicidality.
- Unstable medical conditions (e.g., uncontrolled diabetes, uncompensated cardiac issues, heart failure, pulmonary issues, or chronic obstructive pulmonary disease);
- Absence of weakness as per the NIHSS (0 points = no drift for motor arm and leg items) or severe motor impairment NIHSS 4 points for motor arm).
- Stroke mimics (e.g., infections, medication effects from sedatives, electrolyte imbalances, etc.).
- Stroke worsening between assessments.
Other
- Amputated limbs.
Who the study is looking for
- Providing informed consent to participate in the study.
- Age 18 to 85 years old.
- Clinical presentation and neuroimaging (CTA-CTP/ MRI-MRA) consistent with the diagnosis of Acute Ischemic or Hemorrhagic Stroke.
- Preserved mental status (Glasgow coma score \>12: E(4), V(5), M (4-6)).
- Presence of upper limb weakness per the NIHSS (1-2 points in the arm) and ability to perform testing (i.e., NIHSS motor score 1-2 at elbow, wrist, and finger flexion-extension) within 30 days from stroke. (Note that individuals with a prior ischemic or hemorrhagic stroke with available information pertaining superior extremity baseline strength after their previous stroke would qualify).
- Presence of upper limb weakness per the NIHSS (2 points in the arm) and ability to perform testing (i.e., NIHSS motor score 2 at elbow, wrist, and finger flexion-extension) in subacute stroke. (Note that individuals with a prior ischemic or hemorrhagic stroke with available information pertaining superior extremity baseline strength after their previous stroke would qualify).
- Baseline Modified Rankin score \<4.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ciro Ramos Estebanez, MD., Ph.D., MBA, FNCS. Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
| UH Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.